ArticleThe European respiratory journal2020
JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk.
Puja Mehta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled ittrialcites it